Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $367.78 | 8 | 93.6% |
| Education | $25.00 | 1 | 6.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $140.00 | 2 | $0 (2024) |
| DEXCOM, INC. | $124.99 | 1 | $0 (2021) |
| Lilly USA, LLC | $51.46 | 3 | $0 (2024) |
| Boston Scientific Corporation | $25.78 | 1 | $0 (2022) |
| MannKind Corporation | $25.55 | 1 | $0 (2023) |
| Currax Pharmaceuticals LLC | $25.00 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $66.47 | 4 | Lilly USA, LLC ($51.46) |
| 2023 | $50.55 | 2 | MannKind Corporation ($25.55) |
| 2022 | $150.77 | 2 | Novo Nordisk Inc ($124.99) |
| 2021 | $124.99 | 1 | DEXCOM, INC. ($124.99) |
All Payment Transactions
9 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/17/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $17.35 | General |
| Category: Diabetes | ||||||
| 05/15/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $18.89 | General |
| Category: Diabetes | ||||||
| 03/28/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $15.01 | General |
| Category: Obesity | ||||||
| 01/10/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $15.22 | General |
| Category: Obesity | ||||||
| 08/08/2023 | Currax Pharmaceuticals LLC | NEXLETOL (Drug) | Education | In-kind items and services | $25.00 | General |
| Category: Cholesterol Reducer | ||||||
| 01/12/2023 | MannKind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $25.55 | General |
| Category: DIABETES MEDICINE | ||||||
| 07/11/2022 | Boston Scientific Corporation | WATCHMAN Access System (Device) | Food and Beverage | In-kind items and services | $25.78 | General |
| Category: WATCHMAN_IC | ||||||
| 04/05/2022 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Obesity | ||||||
| 10/19/2021 | DEXCOM, INC. | DEXCOM G6 TRANSMITTER (Device) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: ENDOCRINOLOGY | ||||||
About Sarah Eswar
Sarah Eswar is a Diabetes Educator healthcare provider based in Williamsville, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/07/2015. The National Provider Identifier (NPI) number assigned to this provider is 1649645367.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Sarah Eswar has received a total of $392.78 in payments from pharmaceutical and medical device companies, with $66.47 received in 2024. These payments were reported across 9 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($367.78).
Practice Information
- Specialty Diabetes Educator
- Location Williamsville, NY
- Active Since 12/07/2015
- Last Updated 12/07/2015
- Taxonomy Code 163WD0400X
- Entity Type Individual
- NPI Number 1649645367
Products in Payments
- DEXCOM G6 TRANSMITTER (Device) $124.99
- Saxenda (Drug) $124.99
- JARDIANCE (Drug) $36.24
- WATCHMAN Access System (Device) $25.78
- AFREZZA (Drug) $25.55
- NEXLETOL (Drug) $25.00
- ZEPBOUND (Drug) $15.22
- Wegovy (Drug) $15.01
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.